Inventor · disambiguated record
Hongbo Deng
Also filed as: DENG HONGBO
39 granted patents·19 pending applications·349 citations·filing 2005–2024
98Inventor score
Files withVERTEX PHARMA37ALANTOS PHARM HOLDING6ALANTOS PHARMACEUTICALS INC4MERCK PATENT GMBH4CHARIFSON PAUL S2
Top patents by PatentIndex Score
58 records- 0198US9376448B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Jun 28, 2016·46 cites·10 claims
- 0297US9925188B2DNA-PK inhibitors and uses thereofVERTEX PHARMA·Filed 2016·Granted Mar 27, 2018·24 cites·18 claims
- 0396US9592232B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Mar 14, 2017·24 cites·13 claims
- 0496US9518056B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Dec 13, 2016·16 cites·4 claims
- 0596US9394302B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Jul 19, 2016·19 cites·6 claims
- 0696US9051319B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Jun 9, 2015·24 cites·2 claims
- 0795US9359380B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Jun 7, 2016·19 cites·25 claims
- 0895US9340557B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted May 17, 2016·19 cites·26 claims
- 0995US9296701B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Mar 29, 2016·21 cites·17 claims
- 1095US8829007B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Sep 9, 2014·28 cites·2 claims
- 1194US9878993B2DNA-PK inhibitors for treatment of cancerVERTEX PHARMA·Filed 2016·Granted Jan 30, 2018·10 cites·7 claims
- 1294US9808459B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Nov 7, 2017·11 cites·8 claims
- 1394US9345708B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2014·Granted May 24, 2016·21 cites·16 claims
- 1493US10786512B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·3 cites·8 claims
- 1592US11440907B1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·25 claims
- 1692US10973830B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·3 cites·23 claims
- 1792US10076521B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Sep 18, 2018·7 cites·21 claims
- 1892US10039762B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2017·Granted Aug 7, 2018·7 cites·2 claims
- 1992US9908878B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Mar 6, 2018·8 cites·16 claims
- 2091US10501439B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Dec 10, 2019·5 cites·18 claims
- 2191US10442791B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Oct 15, 2019·5 cites·13 claims
- 2291US10391095B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Aug 27, 2019·5 cites·9 claims
- 2390US9987284B2Substituted benzooxadiazole DNA-PK inhibitorsVERTEX PHARMA·Filed 2016·Granted Jun 5, 2018·5 cites·23 claims
- 2489US10258627B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·4 cites·19 claims
- 2588US11059826B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2019·Granted Jul 13, 2021·3 cites·49 claims
- 2686US12251387B2Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitorsVERTEX PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 2786US11572364B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2021·Granted Feb 7, 2023·1 cites·48 claims
- 2884US2025188070A1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 2979US10815225B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 27, 2020·1 cites·50 claims
- 3077US12195453B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2022·Granted Jan 14, 2025·0 cites·24 claims
- 3177US2021236505A1Substituted quinoxaline dna-pk inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3276US12384790B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·20 claims
- 3376US11813267B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2020·Granted Nov 14, 2023·0 cites·19 claims
- 3476US11021465B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Jun 1, 2021·0 cites·22 claims
- 3575US11008305B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted May 18, 2021·0 cites·20 claims
- 3672US8835441B2Heterobicyclic metalloprotease inhibitorsSTEENECK CHRISTOPH·Filed 2011·Granted Sep 16, 2014·3 cites·10 claims
- 3770US7713966B2Heterobicyclic metalloprotease inhibitorsALANTOS PHARM HOLDING·Filed 2007·Granted May 11, 2010·1 cites·12 claims
- 3869US7795245B2Heterobicyclic metalloprotease inhibitorsATLANTOS PHARMACEUTICALS HOLDI·Filed 2007·Granted Sep 14, 2010·2 cites·15 claims
- 3969US2018311254A1Dna-pk inhibitorsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 4068US10874673B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·30 claims
- 4167US2021040092A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2020·Application pending·0 cites
- 4265US10875855B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·16 claims
- 4365US7749996B2Heterotricyclic metalloprotease inhibitorsALANTOS PHARMACEUTICAL HOLDING·Filed 2007·Granted Jul 6, 2010·1 cites·14 claims
- 4464US2016354381A1Dna-pk inhibitorsObligated Assignee·Filed 2016·Application pending·0 cites
- 4564US2010087420A1Heterotricyclic Metalloprotease InhibitorsALANTOS PHARM HOLDING·Filed 2009·Application pending·0 cites
- 4661US2009312312A1Heterobicyclic Metalloprotease InhibitorsALANTOS PHARM HOLDING·Filed 2009·Application pending·0 cites
- 4756US2007155738A1Heterobicyclic metalloprotease inhibitorsALANTOS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4855US2012171245A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2011·Application pending·0 cites
- 4953US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 5053US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hongbo Deng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →